Logo Cellply

Cellply Named in Cohort 2 of EIC Scaling Club for EU Deep Tech Scale-ups

Events

Cellply Named in Cohort 2 of EIC Scaling Club for EU Deep Tech Scale-ups

Bologna, Italy, November 06, 2024 – Cellply S.r.L, a leader in innovative cellular analysis solutions, formally announces its selection as a member of the EIC Scaling Club, an ecosystem uniting the most promising European deep-tech scale-ups. Cellply joins 120 EU deep tech focused companies, curated by the EIC, with the potential to build world-class businesses solving major global challenges.

“We are thrilled that Cellply has be selected as one of the 12 bio deep tech companies to join the New Biotech Platforms group within the EIC Scaling Club and to be part of this vibrant community dedicated to supporting the success of EU deep tech. This is recognition of our game-changing innovation and commercial success to date,” said Emiliano Spagnolo, Chief Executive Officer at Cellply.

EIC Scaling Club is an EIC-funded initiative established to connect the region’s best and most-promising deep-tech scale-ups with an ecosystem focused on spurring the growth of these innovation-driven companies.

Now formally part of the New Biotech Platforms group, leadership from Cellply attended the Scale 100 Forum in Athens, Greece, October 21-22, 2024 where representatives from both cohort 1 and cohort 2 met investors, corporate partners, mentors and each other.

Dr Massimo Bocchi, co-founder and Chief Strategy Officer at Cellply, commented: “Attending the Scale 100 forum allowed us to meet like-minded leaders and have the rare the opportunity to share our experiences and scale-up challenges. Sourcing funding and navigating the complexity of establishing relationships with large corporates within our sector were common discussion themes.”

The Scale 100 Forum was the Scaling Club’s second organized event, where stakeholders, including Europe’s most active VCs and corporates, top EIC representatives, visionary mentors and industry experts, EU policymakers, and the selected companies, had the chance to meet and network.

Teresa Cunha, Lead at EIC Scaling Club added: “Our EIC Scaling Club proudly supports a diverse group of 120 companies, actively operating across ten prominent deep tech markets, which have collectively raised over €3.4 billion to date. With the backing of more than 400 dedicated club members, these companies are well-positioned to address key global challenges within their respective industries, and I have no doubt they will continue to grow and realise their full potential.”

 

READ THE NEWS OF THE EUROPEAN COMMISSION

 

About EIC Scaling Club:

The EIC Scaling Club is a curated community where 120+ European deep-tech scale-ups with the potential to build world-class businesses and solve significant global challenges come together with investors, corporate innovators, and other industry stakeholders to spur growth. This EIC-funded initiative is run in partnership with Tech Tour, Bpifrance (EuroQuity), Hello Tomorrow, Tech.eu (Webrazzi), EurA, and IESE Business School.

continue reading

You may also like

Webinar

Webinar: A new automated potency analysis technique for suspension cells

25 November 2024
Events

Cellply Introduces Revolutionary High-Throughput Potency Analysis Technique at SITC 39th Annual Meeting

31 October 2024
Webinar

Webinar: Uncovering hidden immune cell killing to understand anti-tumor activity

2 October 2024
Webinar

Cellply is pleased to announce its participation in European Biotech Week 2024 hosting an open webinar exploring the unique assay flexibility of VivaCyte

9 September 2024
News

Eurofins Biopharma Product Testing (BPT) Italy and Cellply announce strategic partnership to foster cell and gene therapy development through single-cell characterisation

29 August 2024
Webinar

Webinar: Rapid single cell functional characterization for cell therapy potency

12 July 2024
News

Cellply passed the phase 2 of Call4Innovit program and will go to San Francisco

23 May 2024
Events

Advancing TCR-based Cell Therapies & Bispecific Approaches

24 April 2024
Press release

Nature Biotechnology publishes research from DKFZ and Cellply highlighting novel approach for accelerating cellular immunotherapy development

19 March 2024
Events

Dual attendance for Cellply at March’s leading events in the cell therapy industry.

18 March 2024
Events

Launch of VivaCyte® at Advanced Therapies Week 2024

26 January 2024
News

Cellply launches its end-to-end single cell potency characterization platform VivaCyte

17 January 2024
Events

Cellply at Advanced Therapies Week 2024

4 January 2024
News

Cellply – Fesr programme 2021-2027

28 December 2023
Press release

Cellply concludes a new internal round of €3.6 million and extends the round to new investors!

27 September 2023
News

CellPly announces acceptance of one abstract at the CICON23 conference

18 September 2023
Press release

CellPly announces Emiliano Spagnolo as the new CEO

27 July 2023
News

L’innovazione Cellply in un articolo sulla rivista Le Scienze

4 March 2020
Events

Cellply to present new method for evaluating immunotherapy efficacy at the 61th ASH Annual Meeting

25 November 2019
News

Cellply wins the €300k Gaetano Marzotto prize and Unicredit StartLab prize

22 November 2018
Events

Cellply invited to present at the World Health Summit 2019

22 October 2018
News

Cellply selected as finalist at Lyfebulb Oncology Award

1 March 2018
Events

Cellply abstract accepted at the AACR 2018 Annual Meeting

4 February 2018
Press release

Cellply and Sant’Orsola-Malpighi Polyclinic to present one abstract on AML patient stratification with the Open Microwell platform at the 58th ASH Annual Meeting

4 November 2016
News

Cellply wins an H2020 SME Instrument Phase 1 grant

20 October 2016
Keep in touch

Need some infos?

Drop us a line or give us a ring. We love to hear from you and are happy to answer any questions.